Shkreli Bid to Overturn $65 Million Daraprim Award Rejected by Supreme Court October 7, 2024 By Greg Stohr The U.S. Supreme Court left in place a $65 million antitrust judgment against Martin Shkreli, the “Pharma Bro” who served...
‘Pharma Bro’ Firm Reaches $40M Settlement in Gouging Case December 9, 2021 SACRAMENTO, Calif. (AP)–A company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations...
Martin Shkreli Accused of Drug Monopoly Scheme by Insurer March 5, 2021 By Mike Leonard A Blue Cross Blue Shield affiliate sued “Pharma Bro” Martin Shkreli, the pharmaceutical industry’s imprisoned enfant terrible, in a Manhattan...